‘Most People Are Going To Get COVID’: US FDA’s Woodcock Not Ready To Shift To Endemic Policy
Acting FDA commissioner tell Senate committee that federal priority should be to ensure essential services remain functional as the Omicron variant’s spread continues.
You may also be interested in...
US FDA adds a warning about immune thrombocytopenia, joining the risk of Thrombosis with Thrombocytopenia Syndrome.
Availability of emergency authorization route in US depends upon lack of 'adequate, approved and available alternatives,' but as more vaccines make their way through the BLA process sponsors may find the EUA door slowly closing.
Not only should children age 12 to 15 get a booster, but 16- and 17-year-olds who previously 'may' get a booster, now also 'should' get one, the CDC advisory committee said.